Alexion Pharmaceuticals, Inc.
Compositions and methods for treating craniosynostosis

Last updated:

Abstract:

Provided herein are compositions and methods for treating craniosynostosis. In particular, provided herein are methods of treating and preventing craniosynostosis by administering an isolated TNAP polypeptide or a nucleic acid molecule that encodes a TNAP polypeptide.

Status:
Grant
Type:

Utility

Filling date:

10 Jul 2015

Issue date:

3 Nov 2020